XML 27 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1

Revenue

9 Months Ended

Sep. 30, 2018

Revenue [Abstract]

REVENUE

12. REVENUE

We primarily offer the First Defense^Ò product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians and dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. The demand for animal protein, that must be produced efficiently while insuring food quality and safety, increases as the human population grows. Our products help address the growing human health concern about using less antibiotics in food-producing animals. There were no material changes between the allocation and timing of revenue recognition during the three-month and nine-month periods ended September 30, 2018 (under ASC 606) and the three-month and nine-month periods ended September 30, 2017 (under ASC 605). We do not have any contract assets such as contracts for which we have satisfied the performance obligations but do not yet have the right to bill for or contract liabilities such as customer advances. All trade receivables on our balance sheet are from contracts with customers. We incur no material costs to obtain contracts. As of March 31, 2018, we had a backlog of orders (representing purchase orders received from customers which were not fulfilled or paid) worth approximately $1,245,000 for the First Defense^® product line. Before June 30, 2018 we cleared all of this backlog that was related to orders for our bivalent formats of the First Defense^® product line (which will be re-branded as Dual-Force^™ First Defense^Ò). As of September 30, 2018, we had a backlog of orders forTri-Shield First Defense^® worth approximately $301,000. We do not have any contract assets such as contracts for which we have satisfied the performance obligations but do not yet have the right to bill for or contract liabilities such as customer advances. All trade receivables on our condensed financial statements are from contracts with customers. We incur no material costs to obtain a contract.

The following table presents our product sales disaggregated by geographic area:

		During the Three-Month Period Ended September 30,				During the Nine-Month Period Ended September 30,
		2018				2018
United States		$	1,893,483			$	7,033,232
Other			260,267				1,016,249
Total product sales		$	2,153,750			$	8,049,481

The following table presents our product sales disaggregated by major product category:

		During the Three-Month Period Ended September 30,				During the Nine-Month Period Ended September 30,
		2018				2018
First DefenseÒ product line		$	2,118,655			$	7,783,006
Other animal health			35,095				266,475
Total product sales		$	2,153,750			$	8,049,481

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration